Boca Raton, FL (PRWEB) August 10, 2012
The Institute of Regenerative and Molecular Orthopedics announced this week that it is one of the few centers performing stem cell harvesting and isolation of adipose mesenchymal stem cells. The procedure could lead to the newest frontier in tissue engineering and stem cell treatment.
Offering a unique hybrid of traditional orthopedics and cutting-edge innovations in regenerative medicine, IRMO is a pioneer in developing minimally-invasive an non-surgical solutions for many common orthopedic problems. Addressing issues from tennis elbow injuries to degenerative arthritis, the revolutionary treatments have earned IRMO a reputation for innovation and discovery.
The institute’s recent work with mesenchymal cells is part of its ongoing commitment to research and discovery. Mesenchymal cells are multipotent stem cells that can differentiate themselves into a number of different cells including osteoblasts, chondrocytes and myocytes. More recent discoveries have indicated that MSCs can also differentiate into beta-pancreatic islets cells. Such characteristics could mean that these cells could point the way towards new advances in tissue re-engineering, potentially facilitating the regrowth and repair of damaged tissue and the treatment of mesenchymal tissue disorders.
Those interested in learning more about the Institute’s work in this area can learn more about IRMO at its website at http://www.stemcellorthopedic.com.
Dr. Joseph Purita, a pioneer in the use of the laser in orthopedic surgery, graduated from Georgetown University Medical School and served his surgical internship at the University of Florida Medical Center. Following completion of a residency in orthopedic surgery at University of Miami-Jackson Memorial Hospital, where he served as chief administrative resident, Dr. Purita joined the Boca Raton Orthopedic Group in 1981.